ThomasFHoganMD

Oncology • Morgantown, WV

Professor of Medicine, W VA University

Join to view full profile

Dr. Hogan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hogan's full profile

Already have an account?

Office
1 Stadium Drive
Mary Babb Randolph Cancer Ctr
Morgantown, WV 26506
Phone+1 304-598-4800
Is this information wrong?

Education & Training

West Virginia UniversityResidency, Pathology-Anatomic and Clinical, 1993 - 1996
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1975 - 1979
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1973 - 1975
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1972 - 1973
Virginia Commonwealth University School of MedicineClass of 1972

Certifications & Licensure

WV State Medical License 1982 - 2024
AZ State Medical License 2002 - 2009
WI State Medical License 1975 - 2005
PA State Medical License 1973 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2010 Sep 17
Completed
Phase 2

Publications & Presentations

PubMed

Pluvicto-Induced 18 F-PSMA PET Bone Flare.
Wang, X., Martin, D., Hogan, T., Veselicky, K.> ;Clinical Nuclear Medicine. 2024 Apr 1
First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report.
Mohamad W Salkini, Xuqing Yang, Fayyaz Haider Hashmi, Stanley J Kandzari, Thomas Hogan, Chad Morley, David Zekan, Dorian J Williams, Y I Guo, Thomas Lewis Matthew, Mic...> ;Anticancer Research. 2022 Mar 1
2 citations
Review of Palliative 223Ra in Metastatic Castration-Resistant Prostate Cancer: Experience at West Virginia University Cancer Center
Ruta Arays, Zeeshan Ahmad, Lorinda Howard, Kenneth Veselicky, Joanna Kolodney, SijinWen, Thomas F. Hogan> ;Journal of Nuclear Medicine Technology. 2021 Mar 1
5 citations
Smoking is associated with adrenal adenomas and adrenocortical carcinomas: a nationwide multicenter analysis
Ahmed Yousaf, Jessica Patterson, Gerald R. Hobbs, Stephen M. Davis, Muhammad Yousaf, Maria Hafez, Heidar Albandar, Thomas F. Hogan, Joanna Kolodney> ;Cancer Treatment and Research Communications. 2020 Jan 1
5 citations
Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and Carboplatin.
Jing Jie Yu, Thomas F. Hogan, Chad Morley, Chad Crigger, Shunchang Jiao, Dorian Williams, Mohamad W Salkini, Xuqing Yang, Xiaobing Liang, Bingxue Yan, Courtney Cecil, ...> ;Anticancer Research. 2019 Aug 1
Audit of the current drug shortage.
Gerald M Higa, Noreen Ghani, Michelle Gianni, Thomas F. Hogan> ;The West Virginia Medical Journal. 2013 Sep 1
3 citations
Malignant Paraganglioma of the Urinary Bladder in a 45-Year-Old Woman
Amruth R. Palla, Thomas F. Hogan, Sindhu Singh> ;Clinical Advances in Hematology & Oncology. 2012 Dec 1
2 citations
Unusual presentation of a left testicular carcinoid.
Amruth R. Palla, Thomas F. Hogan, Sindhu Singh> ;Case Reports in Oncology. 2012 Jan 1
Significance of MTHFR gene mutation with normal homocysteine level in vascular events.
Gadiyaram VK, Khan MA, Hogan T, Altaha R, Crowell E, Hobbs G, Perrota P> ;J. Clin. Oncol.. 2009-05-20
20 citations
Oncocytic, focally anaplastic, thyroid cancer responding to erlotinib.
Thomas F. Hogan, Jing Jie Yu, H James Williams, Ramin Altaha, Xiaobing Liang, Qi He> ;Journal of Oncology Pharmacy Practice. 2009 Mar 10
Phase II study of combined modality treatment for patients with potentially curable esophageal carcinoma.
Adumala R, Sharma M, Khan M, Gadiyaram V, Gayam S, Hobbs G, Kurian S, Hogan T, Higa GM, Auber ML> ;J. Clin. Oncol.. 2008-05-20
37 citations
Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer
David P. Steensma, Roy Molina, Jeff A. Sloan, Daniel A. Nikcevich, Paul L. Schaefer, Kendrith M. Rowland, Todor Dentchev, Paul J. Novotny, Loren K. Tschetter, Steven R...> ;Journal of Clinical Oncology. 2006 Mar 1
Cisplatin, gemcitabine and paclitaxel triplet chemotherapy in 50 patients with advanced or metastatic urothelial cancer.
Thomas F. Hogan, Donald L. Lamm, Gisa B. Schuun, Jose L. Hernadez, Stanley J. Kandzari> ;The West Virginia Medical Journal. 2006 Mar 1
Integrative tumor board: transitional cell carcinoma of the bladder.
Feng, A. Y.,Hogan, T. F.,Lamm, D. L.,Yarnell, E.,Philhower, M.,Krise, M.,Lundy, V. J.,Block, K. I.> ;Integr Cancer Ther. 2005 Mar
64 citations
A pathologist's perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination.
Roger S. Riley, Thomas F. Hogan, Dawn R. Pavot, Robert Forysthe, Davis Massey, Eileen Smith, Lou Wright, Jonathan Ben-Ezra> ;Journal of Clinical Laboratory Analysis. 2004 Jan 1
4 citations
Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia:: a case report and review of the literature
Sobha Kurian, Thomas F. Hogan, Ona C. Bleigh, Yvonne G. Dowdy, Taha Merghoub, Pier Paolo Pandolfi, Sharon L. Wenger> ;Cancer Genetics and Cytogenetics. 2002 Oct 15
Smoking and renal cell carcinoma.
Thomas F. Hogan, Donald L. Lamm, Alan M. Ducatman> ;The West Virginia Medical Journal. 2001 Jan 1
19 citations
Smoking and bladder cancer.
Thomas F. Hogan, Donald L. Lamm, Dale R. Riggs, Alan M. Ducatman> ;The West Virginia Medical Journal. 2001 Jan 1
16 citations
Multi-drug resistance in chronic lymphocytic leukemia.
William R. Friedenberg, Susan K. Spencer, Cynthia Musser, Thomas F. Hogan, Keith A. Rodvold, Daniel A. Rushing, Joseph J. Mazza, Duane A. Tewksbury, James J. Marx> ;Leukemia & Lymphoma. 1999 Jan 1
6 citations
Rapid diagnosis of acute eosinophilic pneumonia (AEP) in a patient with respiratory failure using bronchoalveolar lavage (BAL) with calcofluor white (CW) staining.
Thomas F. Hogan, Roger S. Riley, John G. Thomas> ;Journal of Clinical Laboratory Analysis. 1997 Jan 1
50 citations
Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma.
Ruth A. Decker, Paul Elson, Tom F. Hogan, D. L. Citrin, David W. Westring, Tarit K. Banerjee, Kennedy W. Gilchrist, John Horton> ;Surgery. 1991 Dec 1
25 citations
High Dose Ketoconazole for the Treatment of Hormone Refractory Metastatic Prostate Carcinoma: 16 Cases and Review of the Literature
Steven J. Jubelirer, Thomas F. Hogan> ;The Journal of Urology. 1989 Jul 1
6 citations
Chromatographic studies of mitomycin C degradation in albumin microspheres.
Rahul C. Mehta, Thomas F. Hogan, Seyed Mardmomen, Joseph K. H. Ma> ;Journal of Chromatography. 1988 Jan 1
CNS drug sanctuary effect. Spinal cord metastasis in transitional cell carcinoma.
Roy EP, Corey AL, Marano GD, Hogan TF> ;W V Med J. 1987-09-01
Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review.
Hogan TF, Koss W, Murgo AJ, Amato RS, Fontana JA, VanScoy FL> ;J. Clin. Oncol.. 1987-03-01
Join now to see all